The Firm is representing Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC in connection with a bridge financing to Thermo Fisher Scientific Inc. in its announced tender offer for the acquisition of Patheon N.V for approximately $7.2 billion (including the assumption of debt). The proceeds of the bridge facility will be available to finance the acquisition, to repay certain indebtedness of Patheon and to pay fees and expenses related thereto.
Thermo Fisher, the world leader in serving science, has approximately 50,000 employees and serves customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. Patheon is a Netherlands-based leading provider of formulation development services, active pharmaceutical ingredient manufacturing, and finished dose manufacturing services to biopharmaceutical companies.
The Simpson Thacher team includes Patrick Ryan and Christine Marshall (Banking and Credit); Mark Brod, Tadashi Okamoto and Jonathan Zane (Capital Markets); Edward Chung (Mergers & Acquisitions), Morgan Otway (Tax); Larry Moss and Christopher Scavone (Executive Compensation and Employee Benefits); Lori Lesser, Amber Harezlak and Larry Huang (Intellectual Property); and Michael Isby (Environmental).